Alpha Tau Medical (DRTS) Consolidated Net Income (2021 - 2026)
Alpha Tau Medical (DRTS) posted Consolidated Net Income of $22.9 million for Q1 2026, up 87.93% sequentially from $12.2 million in Q4 2025, and up 166.98% YoY from $8.6 million in Q1 2025.
Alpha Tau Medical (DRTS) Consolidated Net Income (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Consolidated Net Income for 6 years, with the latest figure at $22.9 million in Q1 2026.
- Quarterly Consolidated Net Income rose 166.98% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.8 million (up 75.67% YoY) and the FY2025 annual result came in at $42.4 million, up 33.55% from the prior year.
- Consolidated Net Income improved to $22.9 million in Q1 2026 per DRTS's latest filing, from $12.2 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $25.7 million in Q1 2022 and troughed at $2.0 million in Q2 2022.
- A 5-year average of $9.4 million and a median of $8.1 million in 2023 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2022 and 2023: Consolidated Net Income sank 71.42% in 2022, then soared 334.88% in 2023.
- Over 5 years, Consolidated Net Income stood at $3.4 million in 2022, then soared by 116.78% to $7.3 million in 2023, then advanced by 28.89% to $9.5 million in 2024, then advanced by 28.86% to $12.2 million in 2025, then soared by 87.93% to $22.9 million in 2026.
- According to Business Quant data, Consolidated Net Income over the past three periods registered $22.9 million, $12.2 million, and $11.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 482.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 930.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | -91.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -91.48 Mn |
| Mar 31, 2026 | 22.94 Mn |
| Dec 31, 2025 | 12.21 Mn |
| Sep 30, 2025 | 11.70 Mn |
| Jun 30, 2025 | 9.98 Mn |
| Mar 31, 2025 | 8.59 Mn |
| Dec 31, 2024 | 9.47 Mn |
| Sep 30, 2024 | 6.92 Mn |
| Jun 30, 2024 | 7.36 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Sep 30, 2023 | 4.99 Mn |
| Jun 30, 2023 | 8.64 Mn |
| Mar 31, 2023 | 8.15 Mn |
| Dec 31, 2022 | 3.39 Mn |
| Sep 30, 2022 | 2.61 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 25.74 Mn |
| Dec 31, 2021 | 3.81 Mn |
| Sep 30, 2021 | 4.81 Mn |